Adam S. Butterworth

Adam S. Butterworth

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Adam S. Butterworth

University of Cambridge

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2013 in Genetic Epidemiology
Verified
Journal Article
Open access
PDF file
SBStephen Burgess
Stephen Burgess
ABAdam Butterworth
Adam Butterworth
STSimon G. Thompson
Simon G. Thompson
Genome‐wide association studies, which typically report regression coefficients summarizing the associations of many genetic variants with various traits, are potentially a powerful source of data for Mendelian randomization investigations. We demonstrate how such coefficients from multiple variants can be combined in a Mendelian randomization analysis to estimate the causal effect of a risk factor on an outcome. The bias and efficiency of estimates based on summarized data are compared to those based on individual‐level data in simulation studies. We investigate the impact of gene–gene interactions, linkage disequilibrium, and ‘weak instruments’ on these estimates. Both an inverse‐variance weighted average of variant‐specific associations and a likelihood‐based approach for summarized data give similar estimates and precision to the two‐stage least squares method for individual‐level data, even when there are gene–gene interactions. However, these summarized data methods overstate precision when variants are in linkage disequilibrium. If the P‐value in a linear regression of the risk factor for each variant is less than , then weak instrument bias will be small. We use these methods to estimate the causal association of low‐density lipoprotein cholesterol (LDL‐C) on coronary artery disease using published data on five genetic variants. A 30% reduction in LDL‐C is estimated to reduce coronary artery disease risk by 67% (95% CI: 54% to 76%). We conclude that Mendelian randomization investigations using summarized data from uncorrelated variants are similarly efficient to those using individual‐level data, although the necessary assumptions cannot be so fully assessed.

6 June 2018 in Nature
Verified
Journal Article
Open access
PDF file
BSBenjamin B. Sun
Benjamin B. Sun
JMJoseph C. Maranville
Joseph C. Maranville
JPJames E. Peters
James E. Peters
DSDavid Stacey
David Stacey
JSJames R. Staley
James R. Staley
ABAdam S. Butterworth
Adam S. Butterworth
Although plasma proteins have important roles in biological processes and are the direct targets of many drugs, the genetic factors that control inter-individual variation in plasma protein levels are not well understood. Here we characterize the genetic architecture of the human plasma proteome in healthy blood donors from the INTERVAL study. We identify 1,927 genetic associations with 1,478 proteins, a fourfold increase on existing knowledge, including trans associations for 1,104 proteins. To understand the consequences of perturbations in plasma protein levels, we apply an integrated approach that links genetic variation with biological pathway, disease, and drug databases. We show that protein quantitative trait loci overlap with gene expression quantitative trait loci, as well as with disease-associated loci, and find evidence that protein biomarkers have causal roles in disease using Mendelian randomization analysis. By linking genetic factors to diseases via specific proteins, our analyses highlight potential therapeutic targets, opportunities for matching existing drugs with new disease indications, and potential safety concerns for drugs under development.

17 June 2016 in Bioinformatics
Verified
Journal Article
Open access
PDF file
JSJames R. Staley
James R. Staley
JBJames Blackshaw
James Blackshaw
MKMihir A. Kamat
Mihir A. Kamat
SESteve Ellis
Steve Ellis
PSPraveen Surendran
Praveen Surendran
ABAdam S. Butterworth
Adam S. Butterworth
Summary: PhenoScanner is a curated database of publicly available results from large-scale genetic association studies. This tool aims to facilitate ‘phenome scans’, the cross-referencing of genetic variants with many phenotypes, to help aid understanding of disease pathways and biology. The database currently contains over 350 million association results and over 10 million unique genetic variants, mostly single nucleotide polymorphisms. It is accompanied by a web-based tool that queries the database for associations with user-specified variants, providing results according to the same effect and non-effect alleles for each input variant. The tool provides the option of searching for trait associations with proxies of the input variants, calculated using the European samples from 1000 Genomes and Hapmap. Availability and Implementation: PhenoScanner is available at www.phenoscanner.medschl.cam.ac.uk. Contact:jrs95@medschl.cam.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.

17 September 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TPThe Million Veteran Program
The Million Veteran Program
EEEvangelos Evangelou
Evangelos Evangelou
HWHelen R. Warren
Helen R. Warren
DMDavid Mosen-Ansorena
David Mosen-Ansorena
BMBorbala Mifsud
Borbala Mifsud
MCMark Caulfield
Mark Caulfield
High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease. We report the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry. We identify 535 novel blood pressure loci that not only offer new biological insights into blood pressure regulation but also highlight shared genetic architecture between blood pressure and lifestyle exposures. Our findings identify new biological pathways for blood pressure regulation with potential for improved cardiovascular disease prevention in the future.

1 November 2016 in Cell
Verified
Journal Article
Open access
WAWilliam J. Astle
William J. Astle
HEHeather Elding
Heather Elding
TJTao Jiang
Tao Jiang
DADave Allen
Dave Allen
DRDace Ruklisa
Dace Ruklisa
NSNicole Soranzo
Nicole Soranzo
Many common variants have been associated with hematological traits, but identification of causal genes and pathways has proven challenging. We performed a genome-wide association analysis in the UK Biobank and INTERVAL studies, testing 29.5 million genetic variants for association with 36 red cell, white cell, and platelet properties in 173,480 European-ancestry participants. This effort yielded hundreds of low frequency (<5%) and rare (<1%) variants with a strong impact on blood cell phenotypes. Our data highlight general properties of the allelic architecture of complex traits, including the proportion of the heritable component of each blood trait explained by the polygenic signal across different genome regulatory domains. Finally, through Mendelian randomization, we provide evidence of shared genetic pathways linking blood cell indices with complex pathologies, including autoimmune diseases, schizophrenia, and coronary heart disease and evidence suggesting previously reported population associations between blood cell indices and cardiovascular disease may be non-causal.

7 July 2015 in JAMA
Verified
Journal Article
Open access
PDF file
EAEmanuele Di Angelantonio
Emanuele Di Angelantonio
SKStephen Kaptoge
Stephen Kaptoge
DWDavid Wormser
David Wormser
PWPeter Willeit
Peter Willeit
ABAdam S. Butterworth
Adam S. Butterworth
JDJohn Danesh
John Danesh
The prevalence of cardiometabolic multimorbidity (defined herein as a history of ≥2 of the following: diabetes mellitus, stroke, myocardial infarction [MI]) is increasing rapidly.1-3 Considerable evidence exists about the mortality risk of having any 1 of these conditions alone.4-7 However, evidence is sparse about life expectancy among people who have 2 or 3 cardiometabolic conditions concomitantly. Valid estimation of the associations of cardiometabolic multimorbidity with mortality requires comparison of people with multimorbidity with participants within the same cohorts who did not have any of the conditions at baseline. However, few population cohorts have had sufficient power, detail, and longevity to enable such comparisons.8-14